tiprankstipranks
Advertisement
Advertisement

MEOBF Stock Latest News

Mesoblast receives IND clearance from FDA for Ryoncil trial
The FlyMesoblast receives IND clearance from FDA for Ryoncil trial
3d ago
MESO
Mesoblast Outlines R&D Outlook and Flags Risks Around Stem Cell Pipeline
PremiumCompany Announcements
Mesoblast Outlines R&D Outlook and Flags Risks Around Stem Cell Pipeline
3d ago
Mesoblast Targets Revenue Expansion and Pipeline Upside at Inaugural R&D Day
PremiumCompany Announcements
Mesoblast Targets Revenue Expansion and Pipeline Upside at Inaugural R&D Day
3d ago
Mesoblast Wins FDA Nod for Registrational Ryoncil Trial in Duchenne Muscular Dystrophy
PremiumCompany Announcements
Mesoblast Wins FDA Nod for Registrational Ryoncil Trial in Duchenne Muscular Dystrophy
3d ago
Mesoblast Seeks ASX Quotation for 1.26 Million New Shares
PremiumCompany Announcements
Mesoblast Seeks ASX Quotation for 1.26 Million New Shares
3d ago
Mesoblast reports $30.3M in Ryoncil sales in March quarter
PremiumThe FlyMesoblast reports $30.3M in Ryoncil sales in March quarter
4d ago
MESO
Mesoblast Plans New Share Issue to Raise Capital
Premium
Company Announcements
Mesoblast Plans New Share Issue to Raise Capital
4d ago
Mesoblast reports March quarter Ryoncil sales of $30.3M
Premium
The Fly
Mesoblast reports March quarter Ryoncil sales of $30.3M
4d ago
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
12d ago
NVS
PEW
Mesoblast Earnings Call: Ryoncil Momentum, Pipeline Upside
PremiumCompany Announcements
Mesoblast Earnings Call: Ryoncil Momentum, Pipeline Upside
15d ago
Mesoblast CEO Granted Additional Options Following Shareholder Approval
PremiumCompany Announcements
Mesoblast CEO Granted Additional Options Following Shareholder Approval
22d ago
Mesoblast Issues 3.25 Million Unquoted Options Under Employee Incentive Scheme
PremiumCompany Announcements
Mesoblast Issues 3.25 Million Unquoted Options Under Employee Incentive Scheme
22d ago
Mesoblast Sets Inaugural R&D Day to Showcase Strategy, Ryoncil and Pipeline
PremiumCompany AnnouncementsMesoblast Sets Inaugural R&D Day to Showcase Strategy, Ryoncil and Pipeline
25d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
30d ago
KDK
MPT
Mesoblast hires Regeneron veteran to lead clinical development and medical affairs
Premium
Company Announcements
Mesoblast hires Regeneron veteran to lead clinical development and medical affairs
1M ago
Mesoblast Director Gregory George Deepens Stake with US$16.4m Share Purchases
PremiumCompany Announcements
Mesoblast Director Gregory George Deepens Stake with US$16.4m Share Purchases
1M ago
Mesoblast Rides Ryoncil Launch to Revenue Surge and Advances Late-Stage Cell Therapy Pipeline
PremiumCompany Announcements
Mesoblast Rides Ryoncil Launch to Revenue Surge and Advances Late-Stage Cell Therapy Pipeline
1M ago
Mesoblast Updates Investors on 2025 Results and Operational Outlook
PremiumCompany Announcements
Mesoblast Updates Investors on 2025 Results and Operational Outlook
1M ago
Mesoblast Files Form 6-K Providing Interim Financial and Risk Disclosures
PremiumCompany Announcements
Mesoblast Files Form 6-K Providing Interim Financial and Risk Disclosures
1M ago
Mesoblast to Present Half-Year Results as It Expands Global Cell Therapy Portfolio
PremiumCompany AnnouncementsMesoblast to Present Half-Year Results as It Expands Global Cell Therapy Portfolio
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
GDS
MMM
Mesoblast’s Ryoncil Shows Strong Early Survival in Real-World Use as U.S. Rollout Expands
Premium
Company Announcements
Mesoblast’s Ryoncil Shows Strong Early Survival in Real-World Use as U.S. Rollout Expands
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >